How did LPCUF's recent EPS compare to expectations?
How did Lee's Pharmaceutical Holdings Limited LPCUF's revenue perform in the last quarter?
What is the revenue estimate for Lee's Pharmaceutical Holdings Limited?
What's the earning quality score for Lee's Pharmaceutical Holdings Limited?
When does Lee's Pharmaceutical Holdings Limited report earnings?
What are Lee's Pharmaceutical Holdings Limited's expected earnings?
Did Lee's Pharmaceutical Holdings Limited beat earnings expectations?
Key Stats
Prev.Close
$0.1903
Open
$0.2
Day's Range
$0.1903 - $0.2
52 week range
$0.1882 - $0.2
Volume
6.0K
Avg.Volume
5
EPS (TTM)
0.02
Dividend yield
--
Market Cap
$112.0M
What is LEES PHARMACEUTICAL HLDGS?
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The firm operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The firm's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The firm mainly operates its business in mainland China, Hong Kong and Taiwan.